Safety and Feasibility of Fasting While Receiving Chemotherapy

Fasting (refraining from eating and drinking) during the day is safe while receiving chemotherapy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Fasting Behavior Cancer Chemotherapy Feeding Behavior Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

King Fahad Medical City

Riyadh, Riyadh Region, 11525, Saudi Arabia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age > 18 years
Established diagnosis of cancer
Signed informed consent
Adequate CBC and chemistry to receive chemotherapy

Exclusion criteria

Pregnancy

Treatment and study plan

Primary outcomes

Safety of fasting while receiving chemotherapy

Time frame: two months

Secondary outcomes

Effect of fasting on chemotherapy side effects

Time frame: two months

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

King Fahad Medical City

Other Gov

Registry information

Important dates

Study start: 2008
Primary completion: 2008
Study completion: 2009
First posted: Sep 22, 2008
Registry last updated: Feb 25, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed